You are here

CROs

10 Trends and Statistics for Clinical Trials in 2023

10 Trends and Statistics for Clinical Trials in 2023

Xtalks

clinical trials

Flag link:

Galapagos, following Sanofi’s playbook, offloads French R&D site to drug discovery CRO

Galapagos, following Sanofi’s playbook, offloads French R&D site to drug discovery CRO

Fierce Biotech

Flag link:

Sponsors need to maintain robust oversight of CROs to avoid FDA enforcement action

Sponsors need to maintain robust oversight of CROs to avoid FDA enforcement action

RAPS.org

Flag link:

Growing demand for organ-on-a-chip services prompt CN Bio expansion

Growing demand for organ-on-a-chip services prompt CN Bio expansion

Fierce Biotech

organ-on-a-chip

Flag link:

Europe to suspend about 100 generic drugs after uncovering data 'irregularities' at Indian CRO

Europe to suspend about 100 generic drugs after uncovering data 'irregularities' at Indian CRO

Endpoints

Flag link:

Charles River diving deeper into AI drug development in partnership with Valo Health

Charles River diving deeper into AI drug development in partnership with Valo Health

Fierce Biotech

Charles River Labs

artificial intelligence

Flag link:

Three Companies Join Forces to Become Centricity Research, North America’s Largest lntegrated Research Site Organization

Three Companies Join Forces to Become Centricity Research, North America’s Largest lntegrated Research Site Organization

CP Wire

Centricity Research

True North Clinical Research

Flag link:

CROs embracing tech to decentralize trials and speed enrollment as regulators show support 'with their feet'

CROs embracing tech to decentralize trials and speed enrollment as regulators show support 'with their feet'

Fierce Biotech

clinical trials

decentralized clinical trials

Flag link:

Three Companies Join Forces to Become Centricity Research, North America’s Largest lntegrated Research Site Organization

Centricity Research

True North Clinical Research

Flag link:

CRO owner pleads guilty to obstructing FDA investigation into falsified clinical trial data

CRO owner pleads guilty to obstructing FDA investigation into falsified clinical trial data

Endpoints

clinical trials

Flag link:

New Medtech Accelerator to Launch in 2022

New Medtech Accelerator to Launch in 2022

Medical Devices and Diagnostics Industry

Proxima Clinical Research

Flag link:

Curia to acquire Integrity Bio

Curia to acquire Integrity Bio

Biopharma Reporter

Flag link:

LMC Manna Research Branches into Dermatology

LMC Manna Research Branches into Dermatology

CP WIre

clinical trials

Flag link:

LMC Manna Research Branches into Dermatology

clinical trials

Flag link:

Feds charge another CRO staffer with faking data in a GlaxoSmithKline pediatric asthma study

Feds charge another CRO staffer with faking data in a GlaxoSmithKline pediatric asthma study

Endpoints

Flag link:

Another big CRO deal in the works? Thermo Fisher in talks to acquire PPD for $15B+ — report

Another big CRO deal in the works? Thermo Fisher in talks to acquire PPD for $15B+ — report

Endpoints

ThermoFisher Scientific

Flag link:

The CRO megamerger is back as Icon snaps up PRA Health for $12B

The CRO megamerger is back as Icon snaps up PRA Health for $12B

Fierce Biotech

Icon Biosciences

Flag link:

GSK sells vaccine laboratory activities to Nexelis

GSK sells vaccine laboratory activities to Nexelis

Biopharma Reporter

Flag link:

Charles River bags antibody discovery-focused Distribution Bio for $104M, signaling return to pre-pandemic buyout spree

Charles River bags antibody discovery-focused Distribution Bio for $104M, signaling return to pre-pandemic buyout spree

Endpoints

Charles River Labs

Distribution Bio

Flag link:

Galapagos sells off Fidelta as CRO activities 'no longer fit with its strategy'

Galapagos sells off Fidelta as CRO activities 'no longer fit with its strategy'

Fierce Biotech

Flag link:

Pages